{{ $DoctorName }} @if (isset(session()->get('doctor')['vCentralCode'])) {{ session()->get('doctor')['vCentralCode'] }} @endif
@if (isset(session()->get('doctor')['vCentralCode']))
Logout
@endif

{{ $ActivityTypeName }}

{{ $ActivityName }}

@csrf
@if (isset(session()->get('doctor')['vCentralCode']))
Back
@else
@endif

A disease and management insight survey among dermatologists to understand about dermatophytosis and usage pattern of anti-fungal treatment options in India
Doctor's details
@if (isset(session()->get('doctor')['vCentralCode']))
@else
@endif

@if (isset(session()->get('doctor')['vCentralCode']))
@else
@endif

Questionnaire

  1. What percentage of patients you see in your clinical practice have recalcitrant form of dermatophytosis? *

    		2.

  2. What percentage of your patients with dermatophytosis who are declared clinical cure show relapse? *

    		3.

  3. What are the common causes of relapse of dermatophytosis? *
  4. Which systemic antifungal do you use in your patients with dermatophytosis? *

  5. Do you use two systemic antifungals together in your patients? *

  6. If yes to above question no. 5, which two antifungals together do you prescribe commonly to your patients?
  7. Which form of Itraconazole do you use more commonly in your practice for tinea infection? *

  8. If, using conventional itraconazole, then at what dose and frequency?

  9. If, using super-bioavailable itraconazole, then at what dose and frequency?

  10. Earlier achievement of clinical cure is seen with conventional or super- bioavailable itraconazole? *
  11. What are the major limitations of conventional itraconazole? (Multiple options can be selected) *

  12. For what duration do you advice systemic itraconazole therapy? *

  13. As itraconazole is prone for interaction with other concomitant medications. How do you take care of this situation to avoid the same? *
  14. Which all baseline laboratory investigations you advice before starting itraconazole therapy? (Multiple options can be selected) *

  15. Do you use terbinafine in your patients with dermatophytosis? *

  16. In which patient profile do you prefer to use terbinafine? *
  17. Ciclopirox olamine 1% cream/ lotion has which below mentioned action? (Multiple option can be selected) *

  18. How long does it take to see results from Ciclopirox olamine 1% cream/ lotion in tinea infection? *
  19. At what frequency, do you advice ciclopirox olamine 1% cream/ lotion in tinea infection? *
  20. Which is your preferred topical antifungal to combine with itraconazole *

  21. How is your overall experience of using ciclopirox olamine/zinc pyrithione shampoo in scalp seborrheic dermatitis?*